We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$191M
AUM Growth
-$20.5M
Cap. Flow
-$12.4M
Cap. Flow %
-6.5%
Top 10 Hldgs %
8%
Holding
450
New
8
Increased
100
Reduced
215
Closed
125

Top Buys

Rank Stock Value
1
BIPC icon
Brookfield Infrastructure
BIPC
+$1.03M
2
OXLC
Oxford Lane Capital
OXLC
+$1,000K
3
ECC
Eagle Point Credit Company
ECC
+$951K
4
ORAN
Orange
ORAN
+$441K
5
SNP
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
+$424K

Top Sells

Rank Stock Value
1
DKL icon
Delek Logistics
DKL
+$2.13M
2
WES icon
Western Midstream Partners
WES
+$888K
3
CNXM
CNX Midstream Partners LP
CNXM
+$744K
4
OSB
Norbord Inc.
OSB
+$695K
5
MPC icon
Marathon Petroleum
MPC
+$594K

Sector Composition

Rank Sector Weight
1 Healthcare 32.34%
2 Real Estate 18.02%
3 Energy 12.43%
4 Materials 10.7%
5 Financials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTHX
301
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$193K 0.1%
16,713
-2,278
-12% -$37.6K
BKCC
302
DELISTED
BlackRock Capital Investment Corporation
BKCC
$193K 0.1%
78,942
-14,149
-15% -$37.3K
RCUS icon
303
Arcus Biosciences
RCUS
$3.33B
$190K 0.1%
11,075
-1,524
-12% -$34K
VIE
304
DELISTED
Viela Bio, Inc. Common Stock
VIE
$185K 0.1%
6,584
-902
-12% -$31.9K
RETA
305
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$184K 0.1%
1,893
-253
-12% -$31.6K
TECX
306
Tectonic Therapeutic
TECX
$536M
$183K 0.1%
1,171
-159
-12% -$32K
CUE icon
307
Cue Biopharma
CUE
$118M
$182K 0.1%
402
-55
-12% -$31.7K
CNST
308
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$181K 0.09%
8,940
-1,217
-12% -$29.7K
QURE icon
309
uniQure
QURE
$2.78B
$180K 0.09%
4,893
-654
-12% -$26.8K
FIV
310
DELISTED
First Trust Senior Floating Rate 2022 Target Term Fund Common Shares of Beneficial Interest
FIV
$179K 0.09%
21,201
-6,423
-23% -$54.6K
ORTX
311
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$166K 0.09%
4,029
-550
-12% -$28.4K
FCRD
312
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$159K 0.08%
64,308
-27,171
-30% -$86.8K
APLT
313
DELISTED
Applied Therapeutics
APLT
$157K 0.08%
7,571
-1,034
-12% -$26.9K
ADVM
314
DELISTED
Adverum Biotechnologies
ADVM
$149K 0.08%
1,446
-197
-12% -$29.5K
NXTC icon
315
NextCure
NXTC
$20.4M
$114K 0.06%
1,082
-147
-12% -$18.1K
LQD icon
316
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$113K 0.06%
840
– –
ALEC icon
317
Alector
ALEC
$169M
$111K 0.06%
10,531
-1,429
-12% -$23.1K
TCDA
318
DELISTED
Tricida, Inc. Common Stock
TCDA
$109K 0.06%
12,081
-1,637
-12% -$23.9K
ODT
319
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$109K 0.06%
8,135
-1,109
-12% -$31.4K
CCAP icon
320
Crescent Capital BDC
CCAP
$405M
$87K 0.05%
+6,825
New +$85.4K
CRBP icon
321
Corbus Pharmaceuticals
CRBP
$165M
$80K 0.04%
1,487
-203
-12% -$36.8K
AKBA icon
322
Akebia Therapeutics
AKBA
$338M
$69K 0.04%
27,546
-3,747
-12% -$32.9K
DEN
323
DELISTED
Denbury Inc.
DEN
$14K 0.01%
+777
New +$14.5K
CNX icon
324
CNX Resources
CNX
$4.91B
$12K 0.01%
+1,290
New +$13.2K
CCO icon
325
Clear Channel Outdoor Holdings
CCO
$1.22B
$7K ﹤0.01%
6,654
– –
11 12
13
14 15

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, Virtus ETF Advisers held 450 positions worth $191M, down 9.7% from $211M the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Virtus ETF Advisers withdrew a net $12.4M in Q3 2020, closing 125 positions and reducing 215 holdings. Its most notable exit was CNX Midstream Partners LP, an estimated $744K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Oxford Lane Capital worth $1.03M.

  • Virtus ETF Advisers's largest Q3 2020 buy was Oxford Lane Capital: 46,671 shares worth $1.03M.
  • Virtus ETF Advisers added most to Brookfield Infrastructure in Q3 2020, an estimated $1.03M increase.
  • Virtus ETF Advisers's biggest Q3 2020 reduction was Delek Logistics, cutting an estimated $2.13M.
  • Virtus ETF Advisers fully exited CNX Midstream Partners LP in Q3 2020, selling an estimated $744K.
  • Virtus ETF Advisers's ten largest holdings make up 8% of its $191M portfolio in Q3 2020.
  • Virtus ETF Advisers opened 8 new positions and closed 125 in Q3 2020.
  • Virtus ETF Advisers's portfolio value fell 9.7% quarter-over-quarter to $191M.

Based on Virtus ETF Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.